hotspot -WSS

hotspot

author：focus 2025-10-02 06:02:37 - browse：3431

Susan Tousi is leaving Illumina to become CEO of cancer liquid-biopsy startup Delfi. Nasdaq

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed Susan Tousi, chief commercial officer for genomics giant Illumina, as its new CEO. She is the fourth senior executive to leave Illumina since June.

Tousi will start next week, just in time for the J.P. Morgan Healthcare Conference, while founding CEO Victor Velculescu will remain on the company’s board to help guide its research programs. Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and build on the initial launch of its lung cancer screening test last fall, the latest example of growing interest in the vast and increasingly competitive liquid biopsy market.

Illumina’s own ambitions to enter this space recently came undone after a prolonged battle with U.S. and European regulators finally pushed the company to announce last month that it would divest Grail, which it had acquired for $8 billion two years earlier. Bas Verhoef, Illumina’s head of region for Europe, will serve as interim chief commercial officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Study: People of West African ancestry at greater risk of cardiac amyloidosis

WSS

A clever new way to fix Medicaid and graduate medical education

Sanofi strikes deal with Novavax, boosting the vaccine maker

Telehealth startups turn to complex chronic diseases

Free speech concerns arise in wake of journal editor Eisen's firing

Study: Adult vaccinations pay for themselves in societal benefits

Excited delirium, Elijah McClain, and emergency physicians

knowledge

hotspot

explore

The high cost of giving birth even with insurance

UCSF medical school apologizes for unethical prisoner experiments

Affirmative action in medical school literally saved lives

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Guidelines to prevent youth baseball injuries need more muscle

Telehealth startups turn to complex chronic diseases

How to save PrEP access — and even expand it

Shionogi licenses Pompe disease therapy from Maze Therapeutics

The cancer drug shortage isn’t new — and neither are the solutions

Just how powerful is the placebo effect?

entertainment

More doctors should go into startup world

FDA approves Recor Medical high blood pressure device

UCSF medical school apologizes for unethical prisoner experiments

More doctors should go into startup world

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Google says AlphaFold 3 can map a vast universe of biomolecules

knowledge

entertainment

explore

focus